PubRank

M Zecca

Author PubWeight™ 60.09‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Bartonella-related pseudomembranous angiomatous papillomatosis of the oral cavity associated with allogeneic bone marrow transplantation and oral graft-versus-host disease. Br J Dermatol 2007 1.44
2 The reconstitution of cellular immunity after bone marrow transplantation in children. Haematologica 1992 1.39
3 Preemptive therapy of EBV-related lymphoproliferative disease after pediatric haploidentical stem cell transplantation. Am J Transplant 2007 1.39
4 Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. J Thromb Haemost 2009 1.20
5 Co-infusion of ex vivo-expanded, parental MSCs prevents life-threatening acute GVHD, but does not reduce the risk of graft failure in pediatric patients undergoing allogeneic umbilical cord blood transplantation. Bone Marrow Transplant 2010 1.20
6 Cyclosporin A and short-term methotrexate versus cyclosporin A as graft versus host disease prophylaxis in patients with severe aplastic anemia given allogeneic bone marrow transplantation from an HLA-identical sibling: results of a GITMO/EBMT randomized trial. Blood 2000 1.14
7 Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol 2001 1.14
8 The isochromosome i(7)(q10) carrying c.258+2t>c mutation of the SBDS gene does not promote development of myeloid malignancies in patients with Shwachman syndrome. Leukemia 2009 1.12
9 Graft versus host disease prophylaxis with low-dose cyclosporine-A reduces the risk of relapse in children with acute leukemia given HLA-identical sibling bone marrow transplantation: results of a randomized trial. Blood 2000 1.09
10 A prospective study on children with initial diagnosis of transient hypogammaglobulinemia of infancy: results from the Italian Primary Immunodeficiency Network. Int J Immunopathol Pharmacol 2008 1.08
11 Minimal residual disease is an important predictive factor of outcome in children with relapsed 'high-risk' acute lymphoblastic leukemia. Leukemia 2008 1.07
12 Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection. Am J Transplant 2012 1.07
13 Incidence and treatment of hemorrhagic cystitis in children given hematopoietic stem cell transplantation: a survey from the Italian association of pediatric hematology oncology-bone marrow transplantation group. Bone Marrow Transplant 2003 1.05
14 Improvement over time in outcome for children with acute lymphoblastic leukemia in second remission given hematopoietic stem cell transplantation from unrelated donors. Leukemia 2002 1.03
15 Acute childhood idiopathic thrombocytopenic purpura: AIEOP consensus guidelines for diagnosis and treatment. Associazione Italiana di Ematologia e Oncologia Pediatrica. Haematologica 2000 0.99
16 Itraconazole can increase systemic exposure to busulfan in patients given bone marrow transplantation. GITMO (Gruppo Italiano Trapianto di Midollo Osseo). Anticancer Res 1996 0.98
17 Allogeneic bone marrow transplantation for chronic myelomonocytic leukemia in childhood: a report from the European Working Group on Myelodysplastic Syndrome in Childhood. J Clin Oncol 1997 0.96
18 Extracorporeal photochemotherapy for treatment of acute and chronic GVHD in childhood. Transfusion 2001 0.91
19 T-cell therapy for EBV-associated nasopharyngeal carcinoma: preparative lymphodepleting chemotherapy does not improve clinical results. Ann Oncol 2011 0.90
20 Second allogeneic hematopoietic stem cell transplantation (HSCT) results in outcome similar to that of first HSCT for patients with juvenile myelomonocytic leukemia. Leukemia 2007 0.89
21 Hematopoietic stem cell transplantation for advanced myelodysplastic syndrome in children: results of the EWOG-MDS 98 study. Leukemia 2011 0.88
22 Busulfan. Ann Pharmacother 1994 0.87
23 Incidence of, and risk factors for, nosocomial infections among hematopoietic stem cell transplantation recipients, with impact on procedure-related mortality. Infect Control Hosp Epidemiol 2001 0.86
24 Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing. Bone Marrow Transplant 2003 0.85
25 Human cytomegalovirus (HCMV) infection in paediatric patients given allogeneic bone marrow transplantation: role of early antiviral treatment for HCMV antigenaemia on patients' outcome. Br J Haematol 1994 0.85
26 Late pulmonary sequelae after childhood bone marrow transplantation. Thorax 1999 0.85
27 Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone. Blood 1995 0.84
28 JAK2 V617F mutation is a rare event in juvenile myelomonocytic leukemia. Leukemia 2006 0.84
29 Monosomy 7 in myeloid malignancies: parental origin and monitoring by real-time quantitative PCR. Leukemia 2007 0.84
30 Busulfan, cyclophosphamide and melphalan as conditioning regimen for bone marrow transplantation in children with myelodysplastic syndromes. Leukemia 1994 0.84
31 Mutation analysis of Son of Sevenless in juvenile myelomonocytic leukemia. Leukemia 2007 0.84
32 Aberrant GM-CSF signal transduction pathway in juvenile myelomonocytic leukemia assayed by flow cytometric intracellular STAT5 phosphorylation measurement. Leukemia 2008 0.84
33 Role of magnetic resonance imaging in the diagnosis and prognosis of growth hormone deficiency. Clin Endocrinol (Oxf) 1996 0.83
34 A low thymic function is associated with leukemia relapse in children given T-cell-depleted HLA-haploidentical stem cell transplantation. Leukemia 2012 0.83
35 Myelodysplastic syndromes: the pediatric point of view. Haematologica 1995 0.83
36 Modulating effect of human growth hormone on tumour necrosis factor-alpha and interleukin-1beta. Eur J Endocrinol 1998 0.82
37 Application of wireless inertial measurement units and EMG sensors for studying deglutition - Preliminary results. Conf Proc IEEE Eng Med Biol Soc 2014 0.82
38 Marked and sustained improvement two years after autologous stem cell transplantation in a girl with systemic sclerosis. Arthritis Rheum 1999 0.81
39 Human alloantigen-specific anergic cells induced by a combination of CTLA4-Ig and CsA maintain anti-leukemia and anti-viral cytotoxic responses. Bone Marrow Transplant 2001 0.81
40 Narrowband ultraviolet B phototherapy in the treatment of cutaneous graft-versus-host disease in oncohaematological paediatric patients. Br J Dermatol 2009 0.81
41 Graft-versus-host disease in children: the AIEOP-BMT Group experience with cyclosporin A. Bone Marrow Transplant 1993 0.81
42 Isomorphic cutaneous graft-versus-host disease reaction after ultraviolet exposure: clinical, histological and direct immunofluorescence studies of four allo-transplanted patients. J Eur Acad Dermatol Venereol 2009 0.81
43 T cell therapy for nasopharyngeal carcinoma. J Cancer 2011 0.81
44 Arthroscopic assessment of total hip replacement and polyethylene wear: a case report. Knee Surg Sports Traumatol Arthrosc 2000 0.80
45 Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation. J Clin Immunol 1995 0.80
46 Applicability of a reproducible flow cytometry scoring system in the diagnosis of refractory cytopenia of childhood. Leukemia 2013 0.79
47 Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia. Leukemia 2012 0.79
48 Rhabdomyosarcoma with primary osteolytic lesions simulating non-Hodgkin's lymphoma. Pediatr Hematol Oncol 1991 0.79
49 Total-body irradiation and melphalan is a safe and effective conditioning regimen for autologous bone marrow transplantation in children with acute myeloid leukemia in first remission. The Italian Association for Pediatric Hematology and Oncology-Bone Marrow Transplantation Group. J Clin Oncol 1999 0.78
50 Growth in children after bone marrow transplantation. Horm Res 1993 0.78
51 Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia. Bone Marrow Transplant 1996 0.78
52 A long-term time course of colorimetric assessment of the effects of imatinib mesylate on skin pigmentation: a study of five patients. J Eur Acad Dermatol Venereol 2007 0.78
53 Successful treatment of Griscelli syndrome with unrelated donor allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002 0.77
54 Resolution of immune haemolytic anaemia with allogeneic bone marrow transplantation after an unsuccessful autograft. Br J Haematol 1999 0.77
55 Role of allogeneic bone marrow transplantation for the treatment of myelodysplastic syndromes in childhood. The European Working Group on Childhood Myelodysplastic Syndrome (EWOG-MDS) and the Austria-Germany-Italy (AGI) Bone Marrow Transplantation Registry. Bone Marrow Transplant 1996 0.77
56 Gonadal and uterine function in female survivors treated by chemotherapy, radiotherapy, and/or bone marrow transplantation for childhood malignant and non-malignant diseases. BJOG 2014 0.77
57 Evaluation of growth hormone bioactivity using the Nb2 cell bioassay in children with growth disorders. J Endocrinol Invest 1998 0.77
58 Marked and sustained improvement 2 years after autologous stem cell transplantation in a girl with systemic sclerosis. Rheumatology (Oxford) 1999 0.77
59 Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants. Bone Marrow Transplant 1994 0.77
60 Treatment of chronic childhood immune thrombocytopenic purpura with intramuscular anti-D immunoglobulins. Br J Haematol 1994 0.76
61 A two DoF finger for a biomechatronic artificial hand. Technol Health Care 2002 0.76
62 The immunosuppressive effect of human cytomegalovirus infection in recipients of allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2005 0.76
63 Immunization with Haemophilus influenzae type b conjugate vaccine in children given bone marrow transplantation: comparison with healthy age-matched controls. J Clin Immunol 1998 0.76
64 Successful bone marrow transplantation in children with severe aplastic anemia using HLA-partially matched family donors. Am J Hematol 1993 0.76
65 Frequency of donor cytotoxic T cell precursors does not correlate with occurrence of acute graft-versus-host disease in children transplanted using unrelated donors. J Clin Immunol 1996 0.76
66 Placental-blood transplantation. N Engl J Med 1997 0.75
67 Postnatal variations of growth hormone bioactivity and of growth hormone-dependent factors. Arch Pediatr Adolesc Med 1996 0.75
68 Expression of p75 chain of IL-2 receptor in the early immunological reconstitution after allogeneic bone marrow transplantation. Clin Exp Immunol 1994 0.75
69 Recombinant human granulocyte-macrophage colony stimulating factor (rHuGM-CSF) in cyclic neutropenia. Haematologica 1992 0.75
70 Objective skill analysis and assessment in neurosurgery by using an ultra-miniaturized inertial measurement unit WB-3--pilot tests. Conf Proc IEEE Eng Med Biol Soc 2009 0.75
71 Busulfan as part of conditioning regimen for bone marrow transplantation in children. Bone Marrow Transplant 1991 0.75
72 Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation. Br J Haematol 1992 0.75
73 Polymer-hematite nanocomposites: templating effect of commercial ion-exchangers in the growth of size-controlled iron oxide nanoparticles. J Nanosci Nanotechnol 2013 0.75
74 Pilot trial of combined administration of erythropoietin and granulocyte colony-stimulating factor to children undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1994 0.75
75 Translocation (8;21) in two cases of refractory anemia with excess of blasts in transformation. Cancer Genet Cytogenet 1992 0.75
76 Alloantigen-induced human lymphocytes rendered nonresponsive by a combination of anti-CD80 monoclonal antibodies and cyclosporin-A suppress mixed lymphocyte reaction in vitro. J Immunol 1995 0.75
77 Prophylactic orchiectomy after bone marrow transplantation for boys with acute lymphoblastic leukaemia and previous testicular relapse. Bone Marrow Transplant 1991 0.75
78 Prospective study of endocrine side-effects following bone marrow transplantation in childhood. Bone Marrow Transplant 1991 0.75
79 Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation. Bone Marrow Transplant 1991 0.75
80 Allogeneic transplantation of peripheral blood progenitor cells in children: experience of two pediatric centers. Bone Marrow Transplant 1998 0.75
81 Angular sway propagation in One Leg Stance and quiet stance with Inertial Measurement Units for older adults. Conf Proc IEEE Eng Med Biol Soc 2015 0.75
82 Use of an ultra-miniaturized IMU-based motion capture system for objective evaluation and assessment of walking skills. Conf Proc IEEE Eng Med Biol Soc 2013 0.75
83 Recombinant human erythropoietin may correct erythropoietin-deficient hyporegenerative anaemia in children given cardiac transplantation. Br J Haematol 1994 0.75
84 Does the emergence and persistence of donor-derived leukaemia-reactive cytotoxic T lymphocytes protect patients given an allogeneic BMT from recurrence? Results of a preliminary study. Bone Marrow Transplant 1998 0.75
85 Sustained remission of immune-mediated red cell aplasia in a child after intravenous administration of gamma globulin. J Pediatr 1994 0.75
86 Rehabilitation of chronic graft versus host disease in children. A clinical series. Eura Medicophys 2007 0.75
87 [Bone marrow transplantation in the treatment of severe aplastic anemia]. Pediatr Med Chir 1991 0.75
88 Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation. Br J Haematol 1993 0.75
89 Kinetic analysis of the interaction of mifentidine with gastric H2-receptors in the conscious dog. Naunyn Schmiedebergs Arch Pharmacol 1987 0.75
90 Development of the pituitary and its abnormalities. J Pediatr Endocrinol Metab 1999 0.75
91 Allogeneic bone marrow transplantation in children from other than HLA-identical sibling donor. Bone Marrow Transplant 1991 0.75
92 Disposition of high-dose busulfan in pediatric patients undergoing bone marrow transplantation. Clin Pharmacol Ther 1993 0.75
93 Unrelated donor marrow transplantation for inborn errors. Bone Marrow Transplant 1998 0.75
94 Development of a portable sensorised handle for the objective assessment of the effectiveness and concordance of intervention plans in dementia. Conf Proc IEEE Eng Med Biol Soc 2017 0.75
95 Transplantation of peripheral blood stem cells mobilized by haematopoietic growth factors in childhood. Bone Marrow Transplant 1998 0.75
96 Allogeneic bone marrow transplantation in children from partially matched family donors. Bone Marrow Transplant 1993 0.75
97 Role of allogeneic bone marrow transplantation from an HLA-identical sibling or a matched unrelated donor in the treatment of children with juvenile chronic myeloid leukaemia. Br J Haematol 1996 0.75
98 [Fluoroprophylaxis of dental caries. Current status in the provinces of Genoa and Savona]. Minerva Stomatol 1989 0.75
99 Biomechanical evaluation of the phases during simulated endotracheal intubation (ETI): pilot study on the effect of different laryngoscopes. Conf Proc IEEE Eng Med Biol Soc 2013 0.75
100 Autologous bone marrow transplantation for acute myeloid leukaemia in children using total body irradiation and melphalan as conditioning regimen. Leukemia 1995 0.75
101 Versatile plug flow catalytic cell for in situ transmission/fluorescence x-ray absorption fine structure measurements. Rev Sci Instrum 2013 0.75
102 Bleomycin-induced flagellate dermatitis: report of four paediatric cases. J Eur Acad Dermatol Venereol 2013 0.75
103 Familial haemophagocytic lymphohistiocytosis treated with allogeneic bone marrow transplantation. Bone Marrow Transplant 1991 0.75
104 Development of new muscle contraction sensor to replace sEMG for using in muscles analysis fields. Conf Proc IEEE Eng Med Biol Soc 2014 0.75
105 Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group. Bone Marrow Transplant 1998 0.75
106 Cross-linked polyvinyl polymers versus polyureas as designed supports for catalytically active M(0) nanoclusters. Part III. Nanometer scale structure of the cross-linked polyurea support EnCat 30 and of the Pd(II)/EnCat 30 and Pd(0)/EnCat 30NP catalysts. Phys Chem Chem Phys 2009 0.75